C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2681409
The specific compounds of this list : {7-cyano-2-methyl-1-[4-(morpholine-4-sutfonyl)benzyl]indolizin-3-yl}acetic acid, {1 -(3-chloro-4-ethanesulfonylbenzyl)-7-cyano-2-methylindolizin-3-yl}acetic acid, {1-[3-chloro4-(morpholine-4-sulfonyl)benzyl]-7-cyano-2-methylindolizin-3-yl}acetic acid, {1-(3-chloro-4-ethanesulfonylphenylsulfanyl)-7-cyano-2-methylindolizin-3-yl}acetic acid, {1-[3-chloro-4-(morpholine-4-sutfonyl)phenylsutfanyl]-7-cyano-2-methylindolizin-3- yl}acetic acid, {7-cyano-1 -(6-fluoroquinolin-2-y1methyl)-2-methylindolizin-3-yl}acetic acid are ligands of the CRTH2 receptor and are useful in the treatment of respiratory diseases.
L'invention concerne les composés spécifiques de la liste suivante : acide {7-cyano-2-méthyl-1-[4-(morpholine-4-sulfonyl)benzyl]indolizin-3-yl}acétique, acide {1 -(3-chloro-4-éthanesulfonylbenzyl)-7-cyano-2-méthylindolizin-3-yl}acétique, acide {1-[3-chloro4-(morpholine-4-sulfonyl)benzyl]-7-cyano-2-méthylindolizin-3-yl}acétique, acide {1-(3-chloro-4-éthanesulfonylphénylsulfanyl)-7-cyano-2-méthylindolizin-3-yl}acétique, acide {1-[3-chloro-4-(morpholine-4-sulfonyl)phénylsulfanyl]-7-cyano-2-méthylindolizin-3- yl}acétique, acide {7-cyano-1 -(6-fluoroquinolin-2-ylméthyl)-2-méthylindolizin-3-yl}acétique, lesdits composés étant des ligands du récepteur CRTh2 et se révélant utiles dans le traitement des maladies respiratoires.
Arienzo Rosa
Blaney Paul
Cramp Michael Colin
Finch Harry
Griffon Yann
Argenta Oral Therapeutics Limited
Cassan Maclean
LandOfFree
Indolizine acetic acid derivatives as crth2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolizine acetic acid derivatives as crth2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolizine acetic acid derivatives as crth2 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1859598